
Please try another search
Friday, December 15, 2017
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Salesforce (CRM) and Schwab (SCHW). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Berkshire Hathaway’s shares have gained +20.6% year to date, outperforming the Zacks Property and Casualty Insurance industry which increased +16.9% during the same period. The Zacks analyst likes it inorganic story which has yielded impressive strategic acquisitions.
Continuous investment through strategic buyouts testifies confidence in business environment in the Trump era. The company’s strong cash position allows it to make earnings-accretive bolt-on acquisitions. Demand for utilities is expected to rise in the future and drive earnings growth. Continued insurance business growth also fuels increase in float. A sturdy capital level further adds impetus to the company.
However, the company’s insurance business generates maximum return on equity and thus exposure to catastrophe loss remains a concern. Huge capital expenses on account of railroad operations remain headwinds. Capital expenditure is estimated at $2.6 billion for the remainder of 2017. Also there was no earnings momentum over the last 30 days.
(You can read the full research report on Berkshire Hathaway here >>>).
Shares of Salesforce shares have handily beat the broader Tech sector this year, with the stock up almost double the Zacks Technology sector's +26.8% gain in the year-to-date period. Salesforce reported stellar Q3 results and provided a strong outlook.
The Zacks analyst is also encouraged by the company’s announcement of achieving $10 billion in sales in FY18. The company’s diverse cloud offerings and strong spending on digital marketing remain the catalysts. Additionally, strategic acquisitions and the resultant synergies are anticipated to prove conducive to growth over the long run. Furthermore, the company’s move to utilize Amazon’s data center’s geographical reach to expand its international business is commendable and will help it in achieving its targeted $20 billion sales mark in next few years as well. Nonetheless, stiff competition, currency fluctuations and an increase in investments for international expansions and data centers could negatively impact near-term profitability.
(You can read the full research report on Salesforce here >>>).
Schwab’s shares have outperformed the Zacks Investment Brokers industry over the last three months, gaining +23.5% vs +14.5%. The performance was supported by impressive earnings surprise history, as the company did not lag the Zacks Consensus Estimate in any of the trailing four quarters. The company remains well positioned to gain from the rising rate environment. Also, initiatives to strengthen trading income are likely to support its profitability in the long run despite the near-term reduction in the same. However, continuous rise in expenses (due to rise in compensation costs) remains a key concern for the company. Further, significant dependence on fee-based revenue streams is a major concern.
(You can read the full research report on Schwab here >>>).
Other noteworthy reports we are featuring today include BNY Mellon (BK), SunTrust Banks (NYSE:STI) and Kellogg (K).
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Friday, December 15, 2017
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Salesforce (CRM) and Schwab (SCHW). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Berkshire Hathaway’s shares have gained +20.6% year to date, outperforming the Zacks Property and Casualty Insurance industry which increased +16.9% during the same period. The Zacks analyst likes it inorganic story which has yielded impressive strategic acquisitions. Continuous investment through strategic buyouts testifies confidence in business environment in the Trump era. The company’s strong cash position allows it to make earnings-accretive bolt-on acquisitions. Demand for utilities is expected to rise in the future and drive earnings growth. Continued insurance business growth also fuels increase in float. A sturdy capital level further adds impetus to the company. However, the company’s insurance business generates maximum return on equity and thus exposure to catastrophe loss remains a concern. Huge capital expenses on account of railroad operations remain headwinds. Capital expenditure is estimated at $2.6 billion for the remainder of 2017. Also there was no earnings momentum over the last 30 days.
(You can read the full research report on Berkshire Hathaway here >>>).
Higher Rates Boost BNY Mellon (BK), Concentration Risk A Woe
Per the Zacks analyst, BNY Mellon's margins should continue to benefit from higher rates. Yet, concentration risk arising from its significant dependence on fee income for revenues remains a concern.
Cap-Ex Plans Aids PG&E Corp. (PCG), Catastrophes Hurt
Per the Zacks analyst, PG&E Corp's plan to upgrade infrastructure enhances its service reliability.
Sabina Pass Project Aids Cheniere Energy (LNG), Debt Ails
While the Zacks analyst appreciates Cheniere Energy's favorable competitive position due to solid project execution and strong production at Sabina Pass.
SunTrust Lifted by Higher Rates (STI), Risky Loan Exposure Ails
Per the Zacks analyst, rising rates continue to aid SunTrust's net interest margin. Though, the housing sector is improving, the company's significant exposure to risky loans remains a concern.
Kellogg's (K) Cost Saving Plans Impress, Weak Sales a Woe
Per the Zacks analyst, Kellogg's cost savings from its Project K and ZBB have been supporting renovation, innovation, brand support and margins.
Focus on E-Commerce & Buyouts to Drive United Natural (UNFI)
Per the Zacks analyst, solid focus on e-commerce and buyouts fueled United Natural's sales in the first quarter and are likely to remain major growth drivers.
Solid Cash Position Boosts Centene's (CNC) Growth Potential
Per the Zacks analyst, consistent generation of cash flow boosts Centene's investment capabilities, thereby propelling its long term growth.
Pioneer Natural (PXD) to Gain from Oil-Rich Permian Acreage
Strong focus on the low-cost and lucrative Permian Basin will help Pioneer Natural generate significant cash flow for stockholders, according to the Zacks analyst.
Permian Basin to Drive Concho Resources (CXO) Growth
Concho Resources' large acreage position in the prolific Permian Basin and its competitive cost structure has made the Zacks analyst turn bullish on the E&P company.
Strong Cash Flows Aid Total System's (TSS) Inorganic Growth
Per the Zacks analyst the company derives growth from ample free cash flows from operations which has enabled it to make accretive acquisitions, reduce debt, increase dividend and resume sharebuyback.
Nabors (NBR) Wrecked by CanRig Delays and Cancellations
With a number of clients deferring CanRig equipment deliveries scheduled for the third quarter and numerous orders being canceled, the Zacks analyst has turned bearish on Nabors Industries.
Unisys (UIS) Plagued by Significant Pension Obligations
Per the Zacks analyst, Unisys remains weighed down by significant pension obligations, while incremental investments to thwart competition increase operating expenses and erode profitability.
ABM Industries (ABM) Weighed Down by Competitive Woes
Per the Zacks analyst, strong competitive pressures limit ABM's success rate in bidding for profitable businesses and its ability to increase prices in accordance with the rising costs.
Shares of Caesars Entertainment (NASDAQ:CZR), a leading gambling stock, traded around 3% higher on Wednesday morning, though the stock was trading around 1.5% lower shortly before...
Amazon (NASDAQ:AMZN) is making a significant push into the future with a robust investment in robotics and artificial intelligence. The company has earmarked $35 billion for...
Home Depot’s (NYSE:HD) Q4 2024 report and guidance for 2025 have plenty to be unhappy about, but the simple truth is that this company turned a corner in 2024. It is on track for...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.